spironolactone has been researched along with Emphysema, Mediastinal in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Excerpt | Relevance | Reference |
---|---|---|
"Pneumomediastinum is an uncommon disease arising most frequently and remains largely underdiagnosed clinically, especially in young, healthy patients." | 1.38 | Pneumomediastinum after retching. ( Al, B; Genc, S; Murat, Ç; Sanli, M; Yildirim, C; Zengin, S, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al, B | 1 |
Yildirim, C | 1 |
Zengin, S | 1 |
Murat, Ç | 1 |
Genc, S | 1 |
Sanli, M | 1 |
1 other study available for spironolactone and Emphysema, Mediastinal
Article | Year |
---|---|
Pneumomediastinum after retching.
Topics: Adult; Female; Hirsutism; Humans; Mediastinal Emphysema; Mineralocorticoid Receptor Antagonists; Rad | 2012 |